Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 227 entries
View as:

Vascular Response to Brachytherapy Using Functional OCT

Phase: N/A Priority: Normal
NCT ID: NCT01955941 Org: User:
Start: 10/31/13 End: 11/22/21 Due: 11/22/22

Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00103038 Org: User:
Start: 06/04/04 End: 06/10/16 Due: 06/10/17

Comparing Warm Versus Cool Temperature Water During Colonoscopy

Phase: N/A Priority: Normal
NCT ID: NCT01322724 Org: User:
Start: 06/30/11 End: 04/30/12 Due: 04/30/13

Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00321698 Org: User:
Start: 04/21/06 End: 08/18/23 Due: 08/18/24

Melphalan With BBBD in Treating Patients With Brain Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00253721 Org: User:
Start: 05/31/98 End: 12/31/16 Due: 12/31/17

Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide

Phase: N/A Priority: Normal
NCT ID: NCT02312557 Org: User:
Start: 11/18/14 End: 06/30/25 Due: 06/30/26

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

Phase: N/A Priority: Normal
NCT ID: NCT04996316 Org: User:
Start: 09/07/22 End: 08/31/25 Due: 08/31/26

Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy

Phase: N/A Priority: Normal
NCT ID: NCT04965311 Org: User:
Start: 03/01/23 End: 07/10/24 Due: 07/10/25

Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00253513 Org: User:
Start: 06/30/05 End: 10/31/09 Due: 10/31/10

Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT03097588 Org: User:
Start: 04/27/17 End: 03/20/20 Due: 03/20/21

An Exercise Prehabilitation Intervention for Improving Mobility and Recovery Outcomes in Patients Undergoing Head and Neck Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06079697 Org: User:
Start: 02/01/24 End: 10/31/25 Due: 10/31/26

Ofatumumab and Bortezomib in Subjects With Relapsed CD20+Diffuse Large B Cell, Follicular, or Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01397591 Org: User:
Start: 10/31/11 End: 07/31/13 Due: 07/31/14

Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT04170075 Org: User:
Start: 08/05/19 End: 12/09/22 Due: 12/09/23

Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT02050919 Org: User:
Start: 12/03/13 End: 12/31/20 Due: 12/31/21

Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06398587 Org: User:
Start: 08/01/24 End: 06/07/27 Due: 06/07/28

Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05327738 Org: User:
Start: 12/10/22 End: 12/04/27 Due: 12/04/28

Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01689987 Org: User:
Start: 09/30/12 End: - Due: -

Nestle Impact Advanced Recovery in Improving Surgery Recovery in Patients With Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03261180 Org: User:
Start: 11/30/17 End: 08/09/21 Due: 08/09/22

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00248547 Org: User:
Start: 05/31/04 End: 01/31/09 Due: 01/31/10

Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00074191 Org: User:
Start: 01/31/00 End: 10/31/00 Due: 10/31/01

Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an Option

Phase: N/A Priority: Normal
NCT ID: NCT00740753 Org: User:
Start: 08/31/04 End: 04/28/21 Due: 04/28/22

Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT04850599 Org: User:
Start: 06/14/22 End: 02/21/29 Due: 02/21/30

Pain Management for Head and Neck Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05115825 Org: User:
Start: 04/01/19 End: 05/16/25 Due: 05/16/26

Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02427841 Org: User:
Start: 01/21/16 End: 12/12/22 Due: 12/12/23

A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05453851 Org: User:
Start: 07/01/25 End: 07/01/30 Due: 07/01/31